Search results
Author(s):
Shuo-wen Sun
,
Xing-jie Wang
,
Ruo-chen Yan
,
et al
Added:
1 month ago
Author(s):
Byoung Geol Choi
,
Seung-Woon Rha
,
Se Yeon Choi
,
et al
Added:
10 months ago
Added:
7 months ago
In this week's episode of Parallax, host Dr Ankur Kalra engages in a thought-provoking discussion with Dr Stephen Smith, a pioneer in electrocardiography and myocardial infarction diagnosis. They delve into the groundbreaking OMI/NOMI paradigm (Occlusion MI vs Non-Occlusion MI), challenging the traditional STEMI vs non-STEMI terminology that has long been the cornerstone of acute coronary…
View more
Author(s):
Michelle O'Donoghue
Added:
1 year ago
ESC 23 — Dr Michelle O'Donoghue (Brigham and Women's Hospital, US) outlines a trial update from OCEAN(a)-Dose Extension trial (NCT05581303) in this succinct interview.
OCEAN(a)-DOSE (Amgen) was a dose-finding study aiming to evaluate a siRNA, olpasiran, and its effect on risk for coronary heart disease death, myocardial infarction or urgent coronary revascularization when administered…
View more
Author(s):
Thomas Engstrøm
Added:
3 weeks ago
EuroPCR 25 - 10-year outcomes from DANAMI-3-PRIMULTI show FFR-guided complete revascularisation in ST-elevation myocardial infarction (STEMI) reduces the risk of future events. We are joined by Dr Thomas Engstrøm (University of Copenhagen, Copenhagen, Denmark) to discuss 10-year outcomes from the multicenter, randomized DANAMI-3-PRIMULTI trial investigating FFR-guided complete…
View more
Author(s):
Alexander Fanaroff
Added:
1 year ago
ACC.24 — Dr Alexander Fanaroff (Penn Medicine, US) joins us onsite at ACC.24 to discuss the findings from the BE ACTIVE study, which investigated behavioural economic approaches to increasing physical activity (PA) in patients with an elevated risk of cardiovascular disease (NCT03911141).This randomized, controlled trial enrolled 1062 patients with a 10-year atherosclerotic cardiovascular risk…
View more
Author(s):
Jacob Thomsen Lønborg
Added:
3 weeks ago
EuroPCR 25 - 10-year follow-up findings of DANAMI-3-DEFER show a deferred stenting strategy may reduce HF hospitalisation in ST-elevation myocardial infarction (STEMI) patients.We are joined by Dr Jacob Lønborg (Rigshospitalet, Copenhagen, DK) to discuss key findings from the 10-year follow-up of the DANAMI-3-DEFER (NCT01435408) trial. This randomized controlled trial compared deferred stent…
View more
Author(s):
William E Boden
,
Juan Carlos Kaski
,
C Noel Bairey Merz
,
et al
Added:
1 month ago
TCT 23: PICSO-AMI-I
Author(s):
Giovanni Luigi Di Maria
Added:
1 year ago
Video
Echo-stress in Myocardial Bridge
Author(s):
Priscilla Lamendola
,
Nello Cambise
,
Antonio Di Renzo
,
et al
Added:
12 months ago
Article